The pandemic placed tremendous pressure on the pharmaceutical sector globally, and its impact on Indian pharma was no different. What emerged was an accelerated push in a direction that was previously set but now looked at with renewed vigor – ‘digital transformation’. This was one of the key enablers that allowed the pharma sector to push innovation and productivity through limitations of the pandemic.
This year, Pharmavision’s 13th annual edition delves into India Pharma Inc.’s technology transformation journey, its effect on organizations, their digital roadmap and its impact on patient health and outcomes.